The Relationship of Gastrin Levels with Obesity Anthropometrics, Lipid, Glucose, and Insulin Levels in Children and Adolescents with Obesity

Abstract

The aim of the study was to compare the gastrin levels in obese and healthy children and to investigate the relationship of gastrin with obesity anthropometrics, lipid, and baseline insulin levels, and oral glucose tolerance test scores. Gastrin was significantly lower in the obese group compared with the control group (p > 0.001). Gastrin level displayed a negative correlation with body weight, body weight standard deviation, and insulin levels in oral glucose tolerance test at 120 minutes, a positive correlation with glycohemoglobin A_1c.The results revealed that there is a significant difference between the gastrin levels in obese and healthy children.

Keywords

obesity - gastrin - glucose

• References

• 1 Stern MP, Williams K, Gonzales-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 2004; 27 (11) 2676-2681
• 2 Muscelli E, Mari A, Casolaro A , et al. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 2008; 57 (5) 1340-1348
• 3 Suarez-Pinzon WL, Power RF, Yan Y, Wasserfall C, Atkinson M, Rabinovitch A. Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes 2008; 57 (12) 3281-3288
• 4 Suarez-Pinzon WL, Yan Y, Rabinovitch A. Combination therapy with gastrin and glucagon-like peptide-1 (GLP-1) restores pancreatic insulin content and corrects hyperglycemia after diabetes onset in NOD mice. Can J Diab 2004; 28: 257
• 5 Rooman I, Lardon J, Bouwens L. Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 2002; 51 (3) 686-690
• 6 Cowey SL, Quast M, Belalcazar LM , et al. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer 2005; 103 (12) 2643-2653
• 7 Inci F, Atmaca M, Ozturk M , et al. Pantoprazole may improve beta cell function and diabetes mellitus. J Endocrinol Invest 2014; 37 (5) 449-454
• 8 Singh PK, Hota D, Dutta P , et al. Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2012; 97 (11) E2105-E2108
• 9 Schubert ML, Makhlouf GM. Neural, hormonal, and paracrine regulation of gastrin and acid secretion. Yale J Biol Med 1992; 65 (6) 553-560 , discussion 621–623
• 10 Miskowiak J, Andersen B, Stadil F, Holst Pedersen J. Serum gastrin and blood glucose levels in gastroplasty for morbid obesity. Scand J Gastroenterol 1984; 19 (5) 669-672
• 11 Stock S, Granström L, Backman L, Matthiesen AS, Uvnäs-Moberg K. Elevated plasma levels of oxytocin in obese subjects before and after gastric banding. Int J Obes 1989; 13 (2) 213-222
• 12 Sztefko K, Rybakowa M, Szafran Z, Sucharski P, Sołtysik-Wilk E, Jaworska W. Blood levels of insulin, glucagon and gastrin following intravenous and oral glucose administration in children with simple obesity. Endokrynol Pol 1988; 39 (5) 253-261
• 13 Gultekin F, Gurbilek M, Vatansev H, Yasar S, Akoz M, Ozturk M. Effect of oral glucose loading on serum gastrin level in pregnant and non-pregnant women. Croat Med J 2001; 42 (2) 151-155
• 14 Smyk J, Smyk J, Smyk I. Serum insulin, growth hormone and gastrin levels in children with growth and body weight disorders [in Polish]. Pediatr Pol 1987; 62 (7) 476-484
• 15 Goncerzewicz M, Socha J. Postprandial gastrinemia and insulinemia in children with malabsorption syndromes [in Polish]. Pediatr Pol 1978; 53 (8) 925-931
• 16 Bonikowska-Zgaińska M. Dependence between the gastrinemia and the insulinemia in children with obesity (author's transl) [in Polish]. Przegl Lek 1980; 37 (2) 309-311
• 17 Zimmet P, Alberti G, Kaufman F , et al; International Diabetes Federation Task Force on Epidemiology and Prevention of Diabetes. The metabolic syndrome in children and adolescents. Lancet 2007; 369 (9579) 2059-2061
• 18 Jelliffe DB. Weight scales for developing regions. Lancet 1968; 2 (7563) 359-360
• 19 World Health Organization. Expert Committee on Physical Status: The Use and Interpretation of Anthropometry Physical Status. Geneva, Switzerland: World Health Organization; 1995
• 20 Zwirska-Korczala K, Konturek SJ, Sodowski M , et al. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol 2007; 58 (1) (Suppl. 01) 13-35
• 21 Rickels MR, Elahi D. Raising serum gastrin to improve glycemic control in (type 2) diabetes: another limb of the enteroinsular axis?. J Clin Endocrinol Metab 2012; 97 (11) 3915-3916
• 22 Lam WF, Masclee AA, Muller ES, Lamers CB. Effect of hyperglycemia on gastric acid secretion and gastrin release induced by intravenous amino acids. Am J Clin Nutr 1995; 61 (6) 1268-1272
• 23 Loud FB, Holst JJ, Rehfeld JF, Christiansen J. Inhibition of gastric acid secretion in humans by glucagon during euglycemia, hyperglycemia, and hypoglycemia. Dig Dis Sci 1988; 33 (5) 530-534
• 24 Boj-Carceller D, Bocos-Terraz P, Moreno-Vernis M, Sanz-Paris A, Trincado-Aznar P, Albero-Gamboa R. Are proton pump inhibitors a new antidiabetic drug? A cross sectional study. World J Diabetes 2011; 2 (12) 217-220